Skip to main content
editorial
. 2017 Dec;5(23):470. doi: 10.21037/atm.2017.09.22

Figure 1.

Figure 1

The change in estimated glomerular filtration rate (eGFR) and the possible mechanisms for improvement in heart failure due to sodium-glucose cotransporter 2 inhibitors (SGLT2i). The graph was modified from Figure 1 in (9).